Document is current
Any future updates will be listed below
-
Authors
Jelusic, Marija https://orcid.org/0000-0002-1728-4260
Sestan, Mario
Toplak, Natasa
Tamas, Constantin
Vojinovic, Jelena
Zuber, Zbigniew
Wolska-Kusnierz, Beata
Sparchez, Mihaela
Jesenak, Milos
Rusoniene, Skirmante
Stanevica, Valda
Dolezalova, Pavla
Harel, Liora
Uziel, Yosef
Gattorno, Marco
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 28 April 2025
First Online: 23 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: MJ received speaker fee from Novartis. MS and VS declare that they have no conflicts of interest. NT received speakers'honoraria and a travel grant from Novartis. CT received speaker fees and travel grants from Novartis. JV received speaker fees from Novartis, Eli Lilly and Pfizer. ZZ received speaker fees and travel grants from AbbVie, Novartis and Sobi. MSp received speaker fees and travel grants from Novartis and Sobi. MJes received speakers'honoraria from Novartis and Sobi, served as advisory board member for Novartis, Sobi, and AbbVie; and received travel grants from Novartis. SR received travel grants from Novartis. YU received speaker fee from Novartis, Sobi, Pfizer and Abbvie. MG received consultancies and speaker fees from Novartis, Sobi, Boehringer, Kiniksa and Fresenius-Kabi.
